# Summit Therapeutics Inc.: Form 8-K, filed Jun 27, 2024

- Company: [Summit Therapeutics Inc.](/companies/smmt.md) (CIK 1599298)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 16:27 ET
- Period: 2024-06-27
- Accession: 0001599298-24-000103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000103/smmt-20240627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1599298/000159929824000103/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1599298/000159929824000103/smmt-20240627.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001599298-24-000103. Last ingested by Listed: Nov 4, 2026, 19:36 ET. No prices; not investment advice.
